Persistent allergic rhinitis in the course of dust mites allergy. Case discussion

Article Sidebar

PDF (Język Polski)


Published: Sep 19, 2014
Keywords:
persistent allergic rhinitis, dust mite allergens, therapy for allergic rhinitis

Main Article Content

Piotr Rapiejko
1. Klinika Otolaryngologii i Onkologii Laryngologicznej z Klinicznym Oddziałem Chirurgii Czaszkowo-Szczękowo-Twarzowej, Wojskowy Instytut Medyczny w Warszawie. 2. Ośrodek Badania Alergenów Środowiskowych w Warszawie

Abstract

Persistent allergic rhinitis is the most common allergic disease in the population of Poland. Mites and animal derived allergens are main aetiological factors. The exposure to mites allergens is similar during the year, though the highest in cooler months. According to PoSLeNN and ARIA 2010 recommendations intranasal corticosteroids are considered the first line drugs for all stages of persistent allergic rhinitis. The paper presents the case of an 35 year-old man with symptoms of persistent allergic rhinitis in the course of dust mite allergy, and acute sinusitis as the result of complications.

Downloads

Download data is not yet available.

Article Details

How to Cite
Rapiejko , P. (2014). Persistent allergic rhinitis in the course of dust mites allergy. Case discussion. Alergoprofil, 10(3), 67-73. Retrieved from https://journalsmededu.pl/index.php/alergoprofil/article/view/817
Issue
Vol 10 No 3 (2014)
Section
Article

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Fokkens W.J., Lund V.J., Mullol J. et al.: EPOS 2012: European Position Paper on Rhinosinusitis and Nasal Polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50(1): 1-12.
2. Samoliński B., Arcimowicz M. (red.): Polskie Standardy Leczenia Nieżytów Nosa (PoSLeNN). Alergologia Polska 2013: S1.
3. Bousquet J., van Cauwenberge P., Khaltaev N.; Aria Workshop Group; World Health Organization: Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 2001; 108: S147-334.
4. Bousqet J., Khaltaev N., Cruz A.A. et al.: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy 2008; 63(suppl. 86): 8-160.
5. Brożek J.L., Bousquet J., Baena-Cagnani C.E. et al.: Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revison. J. Allergy Clin. Immunol. 2010; 126: 466-476.
6. Rapiejko P.: Alergiczny nieżyt nosa. W: Alergologia – kompendium. Pawliczak R. (red.). Termedia, Poznań 2013: 119-134.
7. Samoliński B., Nowicka A., Wojas O. et al.: Internasal glucocorticosteroids – not only in allergic rhinitis. Otolaryngol. Pol. 2014; 68(2): 51-64.
8. Rapiejko P., Jurkiewicz D.: Donosowe glikokortykosteroidy w leczeniu nieżytów nosa. Terapia 2014; 10: 27-35.
9. Hryniewicz W., Ozorowski T., Radzikowski A. et al.: Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego 2010. Narodowy Instytut Zdrowia, Warszawa 2010.
10. Rapiejko P., Jurkiewicz D.: Zapalenie zatok przynosowych. Terapia 2011; 11-12(265): 31-40.
11. Rapiejko P., Zawisza E., Lipiec A., Modrzyński M.: Wspomaganie antybiotykoterapii zapalenia zatok przynosowych glikokortykosteroidem, pirośluzanem mometazonu, stosowanym donosowo. Terapia 2001; 3: 29-31.
12. Robeego L.M., Xatzipsaliti M., Borrgo L.M.: Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy 2013; 68(9): 1102-1116.